pharma · Atopic Dermatitis Eczema · Plaque Psoriasis · ARQT
Arcutis Biotherapeutics
Arcutis Biotherapeutics clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 2945 Townsgate Rd, Westlake Village, California 91361, US
- Founded
- 2016
- Employees
- 427
- Programs
- 27
- Drugs
- 3
- Patents
- 30
Arcutis Biotherapeutics projects
13 ClinicalTrials.gov programs sponsored by Arcutis Biotherapeutics.
Arcutis Biotherapeutics has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ARQ-151 cream 0.05%
Arcutis Biotherapeutics
Atopic Dermatitis (Eczema)
1 trial -
ARQ-151 cream 0.3%
Arcutis Biotherapeutics
Psoriasis
2 trials -
ARQ-151 cream 0.5%
Arcutis Biotherapeutics
Psoriasis
1 trial -
ARQ-154
Arcutis Biotherapeutics
Seborrheic Dermatitis
1 trial -
ARQ-252 cream 0.3%
Arcutis Biotherapeutics
Chronic Hand Eczema
1 trial -
ARQ-252 cream 0.3%
Arcutis Biotherapeutics
Vitiligo
1 trial -
Roflumilast
Arcutis Biotherapeutics
Plaque Psoriasis
1 trial -
Roflumilast Cream 0.05%
Arcutis Biotherapeutics
Atopic Dermatitis
1 trial -
Roflumilast Cream 0.3%
Arcutis Biotherapeutics
Plaque Psoriasis
1 trial -
Roflumilast Foam 0.3%
Arcutis Biotherapeutics
Seborrheic Dermatitis
1 trial -
Roflumilast foam 0.3%
Arcutis Biotherapeutics
Plaque Psoriasis
1 trial -
Roflumilast topical 0.3% foam
Arcutis Biotherapeutics
Non-segmental Vitiligo
1 trial -
Topical roflumilast 0.3% foam
Arcutis Biotherapeutics
Hidradenitis Suppurativa
1 trial
Frequently asked questions
How many clinical projects does Arcutis Biotherapeutics have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.